- Home
- PMCB vs GELS Comparison
PMCB vs GELS Comparison
Compare PMCB & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- GELS
- Stock Information
- Founded
- PMCB 1996
- GELS 2018
- Country
- PMCB United States
- GELS Australia
- Employees
- PMCB N/A
- GELS N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- GELS
- Sector
- PMCB Health Care
- GELS
- Exchange
- PMCB Nasdaq
- GELS NYSE
- Market Cap
- PMCB 11.4M
- GELS 12.6M
- IPO Year
- PMCB N/A
- GELS 2024
- Fundamental
- Price
- PMCB $1.30
- GELS $1.01
- Analyst Decision
- PMCB
- GELS
- Analyst Count
- PMCB 0
- GELS 0
- Target Price
- PMCB N/A
- GELS N/A
- AVG Volume (30 Days)
- PMCB 15.1K
- GELS 29.2K
- Earning Date
- PMCB 03-17-2025
- GELS 02-15-2025
- Dividend Yield
- PMCB N/A
- GELS N/A
- EPS Growth
- PMCB N/A
- GELS N/A
- EPS
- PMCB 1.29
- GELS N/A
- Revenue
- PMCB N/A
- GELS $95,618.00
- Revenue This Year
- PMCB N/A
- GELS N/A
- Revenue Next Year
- PMCB N/A
- GELS N/A
- P/E Ratio
- PMCB $1.00
- GELS N/A
- Revenue Growth
- PMCB N/A
- GELS N/A
- 52 Week Low
- PMCB $1.22
- GELS $0.90
- 52 Week High
- PMCB $2.55
- GELS $5.50
- Technical
- Relative Strength Index (RSI)
- PMCB 33.22
- GELS N/A
- Support Level
- PMCB $1.22
- GELS N/A
- Resistance Level
- PMCB $1.58
- GELS N/A
- Average True Range (ATR)
- PMCB 0.14
- GELS 0.00
- MACD
- PMCB -0.04
- GELS 0.00
- Stochastic Oscillator
- PMCB 15.59
- GELS 0.00
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.